Appropriateness of the 30-day expected mortality metric in palliative radiation treatment: a narrative review
Inmaculada Navarro-Domenech(Princess Margaret Cancer Centre), Srinivas Raman(Princess Margaret Cancer Centre), Abram Recht(American Society of Clinical Oncology), Yvette M. van der Linden(Netherlands Comprehensive Cancer Organisation), Peter Hoskin(University of Manchester), Johan Menten(Catholic University of America), Edward Chow(Princess Margaret Cancer Centre), Eva Oldenburger(KU Leuven), Nicolaus Andratschke(University Hospital of Zurich), Mateusz Spałek(The Maria Sklodowska-Curie National Research Institute of Oncology), Charles B. Simone(Memorial Sloan Kettering Cancer Center), Jonas Willmann(University of North Texas), Tara Behroozian(Health Sciences Centre), Quynh‐Nhu Nguyen(The University of Texas MD Anderson Cancer Center), Candice Johnstone(Medical College of Wisconsin), Gustavo Nader Marta(Hospital Sírio-Libanês), Stephen Lutz(Blanchard Valley Health System), Lauren Milton(Health Sciences Centre), Joanna Kaźmierska(Poznan University of Medical Sciences), Peter A.S. Johnstone(Naval Medical Center San Diego), Joanne M. van der Velden(Leiden University Medical Center)
Cited by 14
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
|Journal of Clinical Oncology|2001|819